Xr Securities LLC Novartis Ag Call Options Transaction History

Xr Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Jan 13, 2021	SELL	$78.07 - $94.43 $1.15 Million - $1.39 Million	-14,700 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$82.14 - $91.0 $1.21 Million - $1.34 Million	14,700 New	14,700 $38,000
Q3 2019 Oct 03, 2019	SELL	$85.54 - $94.26 $923,832 - $1.02 Million	-10,800 Closed	0 $0
Q2 2019 Jul 10, 2019	SELL	$75.4 - $92.8 $90,480 - $111,360	-1,200 Reduced 10.0%	10,800 $20,000
Q1 2019 Apr 08, 2019	BUY	$75.32 - $86.15 $903,839 - $1.03 Million	12,000 New	12,000 $38,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.